A philanthropic foundation focused on enhancing healthcare, reducing extreme poverty, and expanding access to technology and education globally.

Bill & Melinda Gates Foundation

American Neurological Association (ANA) is a professional society dedicated to academic researchers and physician-scientists aiming to eliminate neurological diseases through education and clinical care. The organization offers tailored professional development and advocacy.

American Neurological Association (ANA)

Brain Research Foundation funds innovative neuroscience research projects, aiming to enhance understanding of the brain and develop treatments.

Brain Research Foundation

National Institute of Neurological Disorders and Stroke focuses on solving mysteries of the brain and nervous system to improve health. Self-described as an official government organization in the United States.

National Institute of Neurological Disorders and Stroke

Biotechnology Research

The National Institutes of Health

Government Administration

NINDS Small Business Programs

National Institute of Neurological Disorders and Stroke (NINDS) | 54,261 followers on LinkedIn. Our mission is to seek knowledge about the brain and nervous system and reduce the burden of neurological disease. | Privacy Notice &amp; Comment Policy

Medical Disclaimer: The advice provided through the NINDS LinkedIn page is for informational purposes only and is not a substitute for professional medical advice. You should consult a healthcare provider in all matters relating to your health.

Commenting Guideline: Please be aware that your comment may be removed if it contains material that is offensive, commercial, or unrelated to this page.

Michael Oshinsky

Director Of Bioinformatics at National Institute of Neurological Disorders and Stroke (NINDS)

Kory R. Johnson, MS, Ph.D.

Amir Tamiz

Neuroscientist, Entrepreneur, & Innovator | MedTech & HealthTech

Elyse Kemmerer White, Ph.D.

National Institute of Neurological Disorders and Stroke (NINDS)

In 2020-2021, NIH Blueprint supported the development and implementation of a short course focused on best-practices and common challenges associated with neural medical device development and translation. The program was a collaborative effort among four investigators from the University of Minnesota, Florida International University, and University of Colorado Denver and featured a series of video lectures and an annual workshop. #NIHBlueprint20

📢 Call for Nominations: Join the IPRCC! 📢 The Interagency Pain Research Coordinating Committee (IPRCC) is now accepting nominations for new members! We’re seeking passionate scientific and public members to contribute to national pain research priorities and improve outcomes for those affected by pain. If you or someone you know is dedicated to advancing pain research, we encourage you to apply! 🗓 Deadline: December 17th, 2024 📑 More info & application details: https://lnkd.in/eFK_-5Xc Help shape the future of pain research—submit your nomination today!

Are you working on innovative, non-addictive pain treatments? Join us for a Webinar on the HEAL Pain Therapeutics Development Program (PTDP)! This webinar aims to inform and answer participants’ questions on the HEAL Pain Therapeutics Development Program (PTDP) and the funding announcement RFA-NS-24-019. Register now: bit.ly/3Alo2AU

Want to accelerate your groundbreaking research in neurological disorders? Join us for a webinar on the NINDS IGNITE Program, a suite of funding opportunities for early-stage translational research. Learn how to secure funding for your innovative ideas, navigate the application process, and get expert tips from NINDS program directors. Register now: https://go.nih.gov/wn6buXa

🎙️#NINDSNervePod Season 5 Episode 4 is OUT NOW! Strengthen your science communication skills with tips and advice for "Crafting Effective Presentations" with special guests Alfredo Quiñones-Hinojosa, Alicia Wooten, and Huda Zoghbi #NINDSSciComm Episode 4 focuses on how presentations are used in traditional science communication and how to effectively present in different forms and venues, with accessibility built in by design. Listen to the episode: https://lnkd.in/eebUi4sQ Watch the episode with ASL interpretation: https://lnkd.in/egpmCSM5

The Neuroscience Research Opportunities to Increase Diversity (NeuroID) program, funded by the NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (ENDURE), has played a transformative role within The University of Puerto Rico-Rio Piedras by: • Establishing a comprehensive and innovative program to guide dozens of Hispanic students toward graduate programs in neuroscience • Fostering a robust mentorship network that supports students throughout their journey to become neuroscientists • Strengthening the neuroscience network in Puerto Rico by bridging the gap between undergraduate teaching universities and research labs across the United States For more information about this impactful program, please read the full article in the Journal of Undergraduate Neuroscience Education: https://lnkd.in/eGZRJ3XK

The NINDS Circuit is intended to keep the neuroscience community up to date on the latest NINDS research highlights, funding opportunities, office spotlights, meetings and events, and news from the NINDS Director. Please subscribe to stay connected!

🗓️Planning ahead for #ABRCMS2024 ? Several NINDS Staff members are heading to Pittsburgh for the Annual Biomedical Research Conference for Minoritized Scientists (ABRCMS)! You’ll have a chance to meet Dr. Michelle Jones-London, Dr. Marguerite Matthews, and Dr. Anahid Ebrahimi in the NINDS Office of Programs to Enhance the Neuroscience Workforce (OPEN), and Ms. Sheniece Guest in the NINDS Intramural Office of Research Training and Career Development. Stop by the NINDS booth (#1428) to meet our team and learn about NIH diversity training grants and research opportunities. And save the date to join NINDS's Dr. Sadhana Jackson and NIH colleagues for "The Joys of Science Research – Connecting Basic, Translational and Clinical Sciences" which will take place Nov 14, 2024 from 3:45 – 4:15 pm ET in the David L. Lawrence Convention Center, Exhibit Hall Theater (Aisle 300).

You Have a Brilliant Mind. Don’t Risk Losing it to High Blood Pressure Many years before you have a stroke or notice dementia, uncontrolled high blood pressure narrows your arteries, decreasing blood to your brain. Take charge of your health today because nobody else can lower your risk of stroke and dementia like you can. For more information, visit: mindyourrisks.nih.gov

Interested in accelerating your small molecule drug discovery and development project? Join us for a Q&A Webinar on the Blueprint Neurotherapeutics Network for Small Molecules (BPN-Small Molecule) program. Learn how the BPN-Small Molecule program can provide non-dilutive support to advance your project from hit-to-lead chemistry through Phase I clinical testing. Register now: bit.ly/3C6t4BE

Metric
Company Name	Bill & Melinda Gates Foundation	American Neurological Association (ANA)	Brain Research Foundation
Symbol
MSH ID	ORG:GATESFOUNDATION	ORG:MYANA	ORG:THEBRF
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Public & Social Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Philanthropy	Medical and Health Professional Associations	Non-profit Research
Country	US	US	US
Stage
Employee Count	2.88K
Website	gatesfoundation.org	myana.org	thebrf.org
LinkedIn	bill	american-neurological-association	brain-research-foundation
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	460.86K	2.03K
Web Traffic Growth	0.28	1.17
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

NIH

GOV:NIH:NINDS

National Institute of Neurological Disorders and Stroke

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue